Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic.
Mohammad MA, Koul S, Olivecrona GK, Gӧtberg M, Tydén P, Rydberg E, Scherstén F, Alfredsson J, Vasko P, Omerovic E, Angerås O, Fröbert O, Calais F, Völz S, Ulvenstam A, Venetsanos D, Yndigegn T, Oldgren J, Sarno G, Grimfjärd P, Persson J, Witt N, Ostenfeld E, Lindahl B, James SK, Erlinge D.
Mohammad MA, et al. Among authors: tyden p.
Heart. 2020 Dec;106(23):1812-1818. doi: 10.1136/heartjnl-2020-317685. Epub 2020 Oct 6.
Heart. 2020.
PMID: 33023905
Free PMC article.
CONCLUSION: The COVID-19 pandemic has significantly reduced the incidence of MI referred for invasive treatment strategy. No differences in overall short-term case fatality or quality of care indicators were observed....
CONCLUSION: The COVID-19 pandemic has significantly reduced the incidence of MI referred for invasive treatment strategy. No differences in …